Skip to main content
. 2019 Mar 3;33(2):611–619. doi: 10.21873/invivo.11518

Table V. Prognostic impact of genetic aberrations in combination with ISS score on progression-free survival (Cox proportional hazards analysis).

graphic file with name in_vivo-33-618-i0001.jpg

HR: Hazard ratio; CI: confidence interval; PFS: progression-free survival. 1Patients without del(17p13) nor t(14;16) nor t(4;14) and ISS I/II; 2Patients with ISS III, or, patients with del(17p13) or t(14;16); 3Patients with t(4;14), regardless of ISS stage.